Background: The most important risk factor for the development of melanoma and non-melanoma skin cancer is thought to be ultraviolet (UV) radiation. To date there is no quantification of the UV exposure of outdoor sports professionals training and competing at high solar UV levels. Methods: During eight stages of the ‘Tour de Suisse’ cycling race, the UV exposure of 6 professional cyclists was monitored with Bacillus subtilis spore film dosimeters. Results: The measurements showed a personal UV exposure between 0.2 minimal erythema dose (MED) during the prologue and 17.2 MED during a mountain stage. The mean daily personal exposure of all full stages (prologue excluded) was 8.1 MED. The personal exposure level determined during these races exceeded international exposure limits by more than 30 times. Conclusion: Therefore UV exposure of sports professionals should be limited by application of sun screens, protective clothing and training/competition at low insolation.
Dr. Matthias Moehrle
Department of Dermatology
Liebermeisterstrasse 25, D–72026 Tübingen (Germany)
Tel. +49 7071 298 4555, Fax +49 7071 293 761
Received: Received: March 31, 2000
Accepted: April 8, 2000
Number of Print Pages : 2
Number of Figures : 1, Number of Tables : 1, Number of References : 8
Dermatology (International Journal for Clinical and Investigative Dermatology)
Founded as ‘Dermatologische Zeitschrift’ by Oskar Lassar (1893–1907); Continued by Erich Hoffmann (1908–1938), continued as ‘Dermatologica’ (1939–1991), by Wilhelm Lutz (1939–1958), Rudolf Schuppli (1959–1985)
Official Organ of the Swiss Society for Dermatology and Venereology; Official Organ of the Belgian Royal Society for Dermatology and Venereology
Vol. 201, No. 1, Year 2000 (Cover Date: 2000)
Journal Editor: J.-H. Saurat, Geneva.
ISSN: 1018–8665 (print), 1421–9832 (Online)
For additional information: http://www.karger.com/journals/drm
Article / Publication Details
Published online: 8/26/2000
Issue release date: 2000
Number of Print Pages: 2
Number of Figures: 1
Number of Tables: 1
ISSN: 1018-8665 (Print)
eISSN: 1421-9832 (Online)
For additional information: http://www.karger.com/DRM
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.